Cocaine plus nicotine mixture enhances induction and expression of behavioral sensitization in rats

被引:6
作者
Barbosa-Mendez, Susana [1 ]
Salazar-Juarez, Alberto [1 ]
机构
[1] Inst Nacl Psiquiatria, Lab Neurofarmacol Conductual Microcirugia & Terap, Subdirecc Invest Clin, Mexico City 14370, DF, Mexico
关键词
Nicotine; Cocaine; Locomotor sensitization; Drug addiction; Mecamylamine; INDUCED DOPAMINE OVERFLOW; CIGARETTE-SMOKING; NUCLEUS-ACCUMBENS; EXTRACELLULAR DOPAMINE; SYNERGISTIC INTERACTIONS; LOCOMOTOR SENSITIZATION; DEPENDENT OUTPATIENTS; TOBACCO SMOKING; TIME-COURSE; MECAMYLAMINE;
D O I
10.1016/j.jpsychires.2018.02.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Psychoactive substance abuse is a health problem worldwide. Has been reported a high prevalence of use of tobacco and cocaine, either separately or in combination. Clinical and animal studies have suggested that the concurrent use of cocaine and nicotine reinforces the potency of one or both drugs and that nicotine may enhance the reinforcing effects of cocaine. Our study evaluated the combined effects of cocaine and nicotine on locomotor activity during the induction and expression phases of locomotor sensitization a physiological mechanism that plays an important role in establishing some of the defining characteristics of drug abuse. Methods: We used Wistar rats which were dosed with cocaine, nicotine or cocaine and nicotine combination and recorded their locomotor activity in different phases of the experiment. Results: We found that a daily dose of cocaine combined with nicotine enhanced cocaine- and nicotine-induced locomotor activity, as well as induction and expression of locomotor sensitization. Moreover, we found that pretreatment with nicotine enhanced the locomotor sensitization expression. Conclusion: These results suggest that concurrent use of cocaine and nicotine may result in co-abuse of these drugs.
引用
收藏
页码:88 / 98
页数:11
相关论文
共 59 条
[1]   Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats [J].
Barbosa-Mendez, Susana ;
Jurado, Noe ;
Matus-Ortega, Maura ;
Martinon, Susana ;
Heinze, Gerardo ;
Salazar-Juarez, Alberto .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 812 :28-37
[2]   Synergistic interactions between mirtazapine and prazosin prevent the induction and expression of behavioral sensitization to cocaine in rats [J].
Barbosa-Mendez, Susana ;
Matus-Ortega, Maura ;
Salazar-Juarez, Alberto .
PHYSIOLOGY & BEHAVIOR, 2017, 180 :137-145
[3]   Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats [J].
Barbosa-Mendez, Susana ;
Matus-Ortega, Maura ;
Flores-Zamora, Anabel ;
Jurado, Noe ;
Salazar-Juarez, Alberto .
PSYCHIATRY RESEARCH, 2017, 254 :301-310
[4]   Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats [J].
Bechtholt, AJ ;
Mark, GP .
PSYCHOPHARMACOLOGY, 2002, 162 (02) :178-185
[5]   Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice [J].
Biala, Grazyna ;
Staniak, Natasza .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (02) :141-147
[6]   Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol [J].
Blomqvist, O ;
Hernandez-Avila, CA ;
Van Kirk, J ;
Rose, JE ;
Kranzler, HR .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (03) :326-331
[7]   The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users [J].
Brewer, Alex J., III ;
Mahoney, James J., III ;
Nerumalla, Chandra S. ;
Newton, Thomas F. ;
De La Garza, Richard, II .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 106 :132-136
[8]  
Budney A J, 1993, J Subst Abuse, V5, P117, DOI 10.1016/0899-3289(93)90056-H
[9]   THE EFFECTS OF NICOTINE ON LOCOMOTOR-ACTIVITY IN NON-TOLERANT AND TOLERANT RATS [J].
CLARKE, PBS ;
KUMAR, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (02) :329-337
[10]   Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats [J].
Collins, SL ;
Izenwasser, S .
NEUROPHARMACOLOGY, 2004, 46 (03) :349-362